Filing Details
- Accession Number:
- 0001181431-10-055864
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-16 14:08:54
- Reporting Period:
- 2010-11-16
- Filing Date:
- 2010-11-16
- Accepted Time:
- 2010-11-16 14:08:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1361103 | Complete Genomics Inc | GNOM | Services-Commercial Physical & Biological Research (8731) | 203226545 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1098643 | P L V Partners Enterprise | C/O Enterprise Partners 2223 Avenida De La Playa, Suite 300 La Jolla CA 92037-3218 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Acquisiton | 2010-11-16 | 176,737 | $0.00 | 176,737 | No | 4 | C | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2010-11-16 | 259,458 | $0.00 | 436,195 | No | 4 | C | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2010-11-16 | 138,794 | $7.56 | 574,989 | No | 4 | X | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-11-16 | 23,133 | $9.00 | 551,856 | No | 4 | F | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2010-11-16 | 17,261 | $7.56 | 569,117 | No | 4 | X | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-11-16 | 14,500 | $9.00 | 554,617 | No | 4 | F | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2010-11-16 | 8,378 | $7.56 | 562,995 | No | 4 | X | Direct | |
Common Stock, Par Value $0.001 | Disposition | 2010-11-16 | 7,038 | $9.00 | 555,957 | No | 4 | F | Direct | |
Common Stock, Par Value $0.001 | Acquisiton | 2010-11-16 | 111,111 | $9.00 | 667,068 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | X | Direct | |
No | 4 | F | Direct | |
No | 4 | X | Direct | |
No | 4 | F | Direct | |
No | 4 | X | Direct | |
No | 4 | F | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series D Preferred Stock | Disposition | 2010-11-16 | 176,737 | $0.00 | 176,737 | $0.00 |
Common Stock | Series E Preferred Stock | Disposition | 2010-11-16 | 259,458 | $0.00 | 259,458 | $0.00 |
Common Stock | Warrant to Purchase Common Stock | Disposition | 2010-11-16 | 138,794 | $0.00 | 138,794 | $1.50 |
Common Stock | Warrant to Purchase Series D Preferred Stock | Disposition | 2010-11-16 | 17,261 | $0.00 | 17,261 | $7.56 |
Common Stock | Warrant to Purchase Series D Preferred Stock | Disposition | 2010-11-16 | 8,378 | $0.00 | 8,378 | $7.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | 2016-08-12 | No | 4 | X | Direct | |
0 | 2014-04-06 | No | 4 | X | Direct | |
0 | 2014-06-12 | No | 4 | X | Direct |
Footnotes
- Each share of Series D and Series E Preferred Stock was automatically converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering.
- The shares are owned by Enterprise Partners V, LP ("Enterprise V"). Enterprise Management Partners V, LLC ("Enterprise V LLC") serves as the general partner of Enterprise V. Andrew E. Senyei, M.D. is a managing director of Enterprise V LLC and shares voting and investment power over the shares held by Enterprise V.
- The securities are immediately convertible.
- The expiration date is not relevant to the conversion of these securities.
- The warrant is immediately exercisable.
- Enterprise V purchased an additional 111,111 shares of Issuer's common stock in connection with the initial public offering at the offering price of $9.00 per share.